Reaction Details Report a problem with these data
Target
Neuromedin-U receptor 2
Ligand
BDBM50262120
Substrate
n/a
Meas. Tech.
ChEBML_1696564
EC50
1.5±n/a nM
Citation
 Nishizawa, N; Kanematsu-Yamaki, Y; Funata, M; Nagai, H; Shimizu, A; Fujita, H; Sakamoto, J; Takekawa, S; Asami, T A potent neuromedin U receptor 2-selective alkylated peptide. Bioorg Med Chem Lett 27:4626-4629 (2017) [PubMed]  Article 
Target
Name:
Neuromedin-U receptor 2
Synonyms:
G-protein coupled receptor FM-4 | G-protein coupled receptor TGR-1 | NMU-R2 | NMU2R | NMU2R | NMUR2 | NMUR2_HUMAN | Neuromedin-U receptor 2 | TGR1
Type:
PROTEIN
Mol. Mass.:
47710.86
Organism:
Homo sapiens (Human)
Description:
ChEMBL_103075
Residue:
415
Sequence:
MSGMEKLQNASWIYQQKLEDPFQKHLNSTEEYLAFLCGPRRSHFFLPVSVVYVPIFVVGVIGNVLVCLVILQHQAMKTPTNYYLFSLAVSDLLVLLLGMPLEVYEMWRNYPFLFGPVGCYFKTALFETVCFASILSITTVSVERYVAILHPFRAKLQSTRRRALRILGIVWGFSVLFSLPNTSIHGIKFHYFPNGSLVPGSATCTVIKPMWIYNFIIQVTSFLFYLLPMTVISVLYYLMALRLKKDKSLEADEGNANIQRPCRKSVNKMLFVLVLVFAICWAPFHIDRLFFSFVEEWSESLAAVFNLVHVVSGVFFYLSSAVNPIIYNLLSRRFQAAFQNVISSFHKQWHSQHDPQLPPAQRNIFLTECHFVELTEDIGPQFPCQSSMHNSHLPAALSSEQMSRTNYQSFHFNKT
  
Inhibitor
Name:
BDBM50262120
Synonyms:
CHEMBL4083670
Type:
Small organic molecule
Emp. Form.:
C98H163N19O22
Mol. Mass.:
1959.4569
SMILES:
CCCCCCCCCCCCCCCCCC(=O)NC[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](CCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NC(C)(Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)NC)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(O)=O |r,wU:116.120,98.101,24.27,wD:30.31,112.116,128.132,58.58,82.84,21.20,(-25.37,-15.68,;-24.04,-16.46,;-22.7,-15.69,;-21.36,-16.47,;-20.03,-15.69,;-18.69,-16.47,;-17.36,-15.69,;-16.03,-16.47,;-14.69,-15.69,;-13.36,-16.47,;-12.02,-15.69,;-10.69,-16.47,;-9.35,-15.69,;-8.01,-16.47,;-6.69,-15.69,;-5.35,-16.47,;-4.02,-15.69,;-2.68,-16.47,;-2.69,-18.01,;-1.35,-15.69,;-.01,-16.47,;1.33,-15.7,;2.66,-16.48,;4,-15.72,;3.99,-14.18,;2.67,-13.41,;1.34,-14.17,;5.33,-13.42,;5.33,-11.88,;6.66,-14.19,;7.99,-13.42,;9.33,-14.2,;10.66,-13.43,;12,-14.21,;11.99,-15.75,;13.34,-13.44,;14.67,-14.2,;16,-13.43,;17.33,-14.2,;18.66,-13.43,;20,-14.2,;21.33,-13.43,;22.66,-14.2,;23.99,-13.43,;25.32,-14.2,;26.65,-13.43,;27.99,-14.2,;29.32,-13.43,;30.65,-14.2,;31.98,-13.43,;33.31,-14.2,;33.31,-15.74,;34.64,-13.43,;35.99,-14.19,;37.31,-13.4,;38.65,-14.15,;38.67,-15.69,;39.97,-13.37,;41.3,-14.14,;41.31,-15.69,;42.64,-16.45,;43.97,-15.69,;45.31,-16.45,;45.31,-18,;46.65,-18.74,;43.97,-18.76,;42.64,-17.99,;42.64,-13.37,;42.64,-11.83,;43.97,-14.14,;45.31,-13.37,;43.97,-12.6,;45.31,-11.83,;46.64,-11.07,;47.98,-11.84,;49.31,-11.07,;49.31,-9.53,;47.98,-8.75,;46.64,-9.53,;46.64,-14.14,;46.64,-15.69,;47.98,-13.38,;49.31,-14.14,;49.32,-15.68,;50.64,-16.45,;51.98,-15.69,;50.64,-18,;50.64,-13.38,;50.65,-11.84,;52,-14.13,;53.35,-13.37,;54.69,-14.14,;54.69,-15.68,;56.02,-16.45,;56.02,-17.98,;53.35,-11.83,;52.02,-11.06,;54.69,-11.04,;54.68,-9.49,;53.34,-8.72,;53.34,-7.18,;54.68,-6.41,;54.69,-4.86,;56.03,-4.09,;57.37,-4.85,;56.04,-2.55,;56.01,-8.72,;56.01,-7.18,;57.35,-9.49,;57.51,-11.02,;59.01,-11.33,;59.78,-10,;58.75,-8.86,;59.07,-7.36,;57.92,-6.32,;60.54,-6.87,;60.58,-5.32,;59.27,-4.52,;59.32,-2.97,;58,-2.17,;58.04,-.62,;56.72,.21,;56.76,1.74,;55.37,-.54,;54.06,.28,;61.93,-4.59,;63.24,-5.39,;61.97,-3.04,;63.34,-2.3,;64.65,-3.1,;66,-2.37,;66.05,-.84,;67.31,-3.18,;63.38,-.76,;62.07,.05,;64.73,-.02,;8,-11.88,;9.33,-11.12,;6.66,-11.1,)|
Structure:
Search PDB for entries with ligand similarity: